Novartis AG logo
Novartis AG NVS
$ 163.96 -1.74%

Annual report 2025
added 02-28-2026

report update icon

Novartis AG Long Term Debt Current 2011-2026 | NVS

Annual Long Term Debt Current Novartis AG

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
263 M 235 M 230 M 251 M 275 M 286 M 246 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
286 M 230 M 255 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
7.09 M $ 20.36 -1.64 % $ 2.57 B usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.81 -4.23 % $ 4.42 M chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
434 K $ 164.64 -1.05 % $ 8.19 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.7 -3.27 % $ 1.11 B canadaCanada
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
1.37 M $ 18.0 0.61 % $ 864 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Certara Certara
CERT
3.92 M $ 7.28 3.19 % $ 1.17 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
749 K $ 26.28 -2.16 % $ 704 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Codexis Codexis
CDXS
2.83 M $ 1.01 -0.49 % $ 74.1 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
437 K $ 23.89 0.04 % $ 2.92 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
2.59 M $ 3.22 -3.59 % $ 1.15 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
18.4 M $ 28.92 -0.96 % $ 1.68 B usaUSA
Champions Oncology Champions Oncology
CSBR
1.47 M $ 5.98 -1.48 % $ 81.7 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
8.38 M $ 3.68 -3.16 % $ 116 M franceFrance
Alector Alector
ALEC
9.06 M $ 2.13 -3.62 % $ 219 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
1.98 M $ 15.77 -1.81 % $ 783 M britainBritain
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Altimmune Altimmune
ALT
279 K $ 4.25 2.04 % $ 302 M usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
2.15 M $ 14.2 1.9 % $ 5.89 B irlandaIrlanda